For comparison of potential association between various types of CAFs and tamoxifen response, we selected patients with ERα-positive breast cancer in cohort I and compared untreated and tamoxifen-treated patients subdivided according to SMAα and pERK. The gene discussed is ESR1; the disease is breast cancer.